Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness.

    Mirzoev TN, Baral SC, Karki DK, Green AT, Newell JN.

    Cost Eff Resour Alloc. 2008 Oct 24;6:20.

    PMID:
    18947436
    [PubMed]
    Free PMC Article
    2.

    [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

    Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

    Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

    PMID:
    15959450
    [PubMed - indexed for MEDLINE]
    3.

    [Tuberculosis in Asia].

    [No authors listed]

    Kekkaku. 2002 Oct;77(10):693-7. Japanese.

    PMID:
    12440145
    [PubMed - indexed for MEDLINE]
    4.

    Costs of a successful public-private partnership for TB control in an urban setting in Nepal.

    Karki DK, Mirzoev TN, Green AT, Newell JN, Baral SC.

    BMC Public Health. 2007 May 18;7:84.

    PMID:
    17511864
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India.

    Floyd K, Arora VK, Murthy KJ, Lonnroth K, Singla N, Akbar Y, Zignol M, Uplekar M.

    Bull World Health Organ. 2006 Jun;84(6):437-45. Epub 2006 Jun 21.

    PMID:
    16799727
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial.

    Newell JN, Baral SC, Pande SB, Bam DS, Malla P.

    Lancet. 2006 Mar 18;367(9514):903-9.

    PMID:
    16546538
    [PubMed - indexed for MEDLINE]
    7.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.

    PMID:
    16904047
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

    Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.

    Health Technol Assess. 2001;5(32):1-195. Review.

    PMID:
    12065068
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.

    Pantoja A, Lönnroth K, Lal SS, Chauhan LS, Uplekar M, Padma MR, Unnikrishnan KP, Rajesh J, Kumar P, Sahu S, Wares F, Floyd K.

    Int J Tuberc Lung Dis. 2009 Jun;13(6):705-12.

    PMID:
    19460245
    [PubMed - indexed for MEDLINE]
    10.

    Feasibility of a community health worker strategy for providing near and appropriate treatment of malaria in southeast Nigeria: an analysis of activities, costs and outcomes.

    Onwujekwe O, Uzochukwu B, Ojukwu J, Dike N, Shu E.

    Acta Trop. 2007 Feb;101(2):95-105. Epub 2007 Jan 31.

    PMID:
    17270139
    [PubMed - indexed for MEDLINE]
    11.

    Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

    Plosker GL, Figgitt DP.

    Pharmacoeconomics. 2004;22(6):389-411. Review.

    PMID:
    15099124
    [PubMed - indexed for MEDLINE]
    12.

    Cost-effectiveness of treating multidrug-resistant tuberculosis.

    Resch SC, Salomon JA, Murray M, Weinstein MC.

    PLoS Med. 2006 Jul;3(7):e241.

    PMID:
    16796403
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.

    Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D.

    Int J Tuberc Lung Dis. 2003 Sep;7(9 Suppl 1):S56-62.

    PMID:
    12971655
    [PubMed - indexed for MEDLINE]
    15.

    Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.

    Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F.

    Int J Tuberc Lung Dis. 2003 Sep;7(9 Suppl 1):S29-37.

    PMID:
    12971652
    [PubMed - indexed for MEDLINE]
    16.

    Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999.

    Adatu F, Odeke R, Mugenyi M, Gargioni G, McCray E, Schneider E, Maher D.

    Int J Tuberc Lung Dis. 2003 Sep;7(9 Suppl 1):S63-71.

    PMID:
    12971656
    [PubMed - indexed for MEDLINE]
    17.

    Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.

    Migliori GB, Ambrosetti M, Besozzi G, Farris B, Nutini S, Saini L, Casali L, Nardini S, Bugiani M, Neri M, Raviglione MC.

    Bull World Health Organ. 1999;77(6):467-76.

    PMID:
    10427931
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.

    Vassall A, Bagdadi S, Bashour H, Zaher H, Maaren PV.

    Int J Tuberc Lung Dis. 2002 Dec;6(12):1083-90.

    PMID:
    12546116
    [PubMed - indexed for MEDLINE]
    19.

    [Development and perspectives of community DOTS].

    Narita T, Kobayashi N.

    Kekkaku. 2009 Apr;84(4):187-201. Japanese.

    PMID:
    19425394
    [PubMed - indexed for MEDLINE]
    20.

    Home treatment for mental health problems: a systematic review.

    Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, Wright C.

    Health Technol Assess. 2001;5(15):1-139. Review.

    PMID:
    11532236
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk